APAC hemostats market is expected to reach USD 595.1 million by 2024, from USD 327.6 million in 2016 growing at a CAGR of 7.8% in the forecast period 2017 to 2024.
The "APAC Hemostats Market" report includes a comprehensive analysis of the present state of the market.
Based on geography, the APAC hemostats market is segmented into 11 geographical regions, such as,
Rest of APAC.
APAC hemostats market competition by top players including -
Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as
Vascular Solutions, Inc.,
3-D Matrix, Ltd.,
Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company),
Anika Therapeutics, Inc.,
Arch Therapeutics Inc.,
Gamma Therapeutics, Inc.,
MedTrade Products Limited, I
ntegra LifeSciences Corporation,
Medline Industries, Inc.,
HEMOTEC MEDICAL GMBH,
The APAC hemostats market is segmented on the basis of type, application, distribution channel, and end user.
The APAC hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.
On the basis of application, the market is segmented into surgery and wound closure.
On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.
Anika Therapeutics, Inc.,, Arch Therapeutics Inc.,, Biom’Up SAS,, CryoLife, Inc.,, Gamma Therapeutics, Inc.,, Hemostasis, LLC,, MedTrade Products Limited, I ntegra LifeSciences Corporation,, Medline Industries, Inc.,, HEMOTEC MEDICAL GMBH,, Stryker,, CSL Behring,, Mallinckrodt,, Equimedical, B.V.
APAC Hemostats Market Table of Content:
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF ASIA PACIFIC HEMOSTATS MARKET
1.4. CURRENCY AND PRICING
1.6. MARKETS COVERED
- MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
- MARKET OVERVIEW
3.1.1. CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES
3.1.2. TECHNOLOGICAL ADVANCEMENTS
3.1.3. INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES
3.1.4. IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING HEALTHCARE SPENDING
3.2.1. RELUCTANCE OF SURGEONS TOWARDS NEW PRODUCTS
3.2.2. WEAK REIMBURSEMENT
3.3.1. UNMET MEDICAL NEEDS
3.3.2. EMERGING MARKET
3.4.1. DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.4.2. LIMITATIONS OF HEMOSTATIC AGENTS IN ACHIEVING HEMOSTASIS
- PREMIUM INSIGHTS
5.2. REGULATORY PROCEDURE
6.2. REIMBURSEMENT SCENARIO
- EXECUTIVE SUMMARY
- ASIA PACIFIC HEMOSTATS MARKET, BY TYPE
8.2. THROMBIN BASED HEMOSTATS
8.3. COMBINATION AGENT HEMOSTATS
8.4. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS
8.5. GELATIN BASED HEMOSTATS
8.6. COLLAGEN BASED HEMOSTATS
- ASIA PACIFIC HEMOSTATS MARKET,BY APPLICATION
9.2. ASIA PACIFIC HEMOSTATS MARKET, BY APPLICATION
9.3. WOUND CLOSURE
9.4. SURGICAL HEMOSTATS
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...